Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Oct 14 - Oct 19
doi:10.2147/ott.s4645
The findings support the potential of this bilayer film as a promising buccal delivery system for GLP-1 RAs, offering a patient-friendly alternative to injectable therapies
Tirzepatide: The weight-loss drug that also shrinks breast tumors in mice Date: July 13, 2025 Source: The Endocrine Society Summary: In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant weight loss in obese mice but also slashed breast cancer tumor growth
PMID 16473858
This does not establish BPC-157 as an FDA-approved ulcerative colitis treatment or validate every claim made about tendon, ligament, joint, or gastrointestinal healing
9-11 Expected side effects of this class of drugs are mainly focused on the gastrointestinal tract
US$ 25.48
US$ 26.77
US$ 20.57
